Preparation, Drug Release, and Cell Growth Inhibition of a Gelatin: Doxorubicin Conjugate
Authors:
- 18 May 2013
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 30 (8) , 2087-2096
Abstract
To demonstrate the feasibility of a novel macromolecular delivery system for doxorubicin (DOX) which combines pH dependent DOX release with a high molecular weight and biodegradable gelatin carrier.Keywords
This publication has 34 references indexed in Scilit:
- Biodegradable star HPMA polymer–drug conjugates: Biodegradability, distribution and anti-tumor efficacyJournal of Controlled Release, 2011
- The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(γ-benzyl l-glutamate)-b-hyaluronan polymersomesBiomaterials, 2010
- In vitroevaluation of surface functionalized gelatin nanoparticles for macrophage targeting in the therapy of visceral leishmaniasisJournal of Drug Targeting, 2009
- Pharmacokinetics and tissue distribution of PGG–paclitaxel, a novel macromolecular formulation of paclitaxel, in nu/nu mice bearing NCI-460 lung cancer xenograftsCancer Chemotherapy and Pharmacology, 2009
- Glomerular permeability to macromolecules in theNecturuskidneyAmerican Journal of Physiology-Renal Physiology, 2009
- A pH‐sensitive nano drug delivery system derived from pullulan/doxorubicin conjugateJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2008
- Polymeric anticancer drugs with pH-controlled activationAdvanced Drug Delivery Reviews, 2004
- The dawning era of polymer therapeuticsNature Reviews Drug Discovery, 2003
- Pharmacokinetics of Pegylated Liposomal DoxorubicinClinical Pharmacokinetics, 2003
- Preparation of protein conjugates via intermolecular hydrazone linkageBiochemistry, 1986